Biocon launches KRABEVA to treat cancer
It is the world’s first and only Bevacizumab with a unique ‘Qual-Check’ mechanism, which will ensure that patients get a…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.